HC Wainwright 22 nd Annual
Date:
Details of the presentation
ATACS: a unique new mode of action to fight cancer
Date:
Speaker : Dr
Access to the presentation: https://wsw.com/webcast/hcw7/hpha.f/1773389
International HealthTech Innovation Days (mixed format)
Date:
Venue: The Peninsula Paris,
Dr.
About
Antibody Drug Conjugates (ADCs) combine the high affinity and specificity of antibodies with the effectiveness of small toxic molecules to fight cancer. ATACs (Antibody Targeted Amanitin Conjugates) are ADCs whose active ingredient consists of amatoxin molecules. Amatoxins are bicyclic peptides that occur naturally in the green leaf agaric. By binding to RNA polymerase II, they inhibit the transcription of the mRNA, a mechanism that is crucial for the survival of eukaryotic cells. In preclinical studies, ATACs have shown a very high level of effectiveness, they overcome common resistance mechanisms and can also fight dormant tumor cells.
Contact:
Tel: +49 89 41 31 38-29
Email: investors[at]hdpharma.com
(C) 2020 Electronic News Publishing, source